Clemastine: Uses, Side Effects, Dosage - Drugvu

ℹ️ Compiled from public regulatory records · Last regulator revision: October 10, 2025🚩 Report this page

Clemastine

Active ingredient · 2 therapeutic classes

GB MHRA

Drug class: Aminoalkyl Ethers
Availability: See label
Markets covered: 1
Products on record: 1

R06AAAminoalkyl Ethers D04AAAntihistamines For Topical Use

Overview

Clemastine is an active pharmaceutical ingredient in the Aminoalkyl Ethers group (R06AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
GB United Kingdom	MHRA	1	October 10, 2025

GBUnited Kingdom· MHRA

1 product

Uses

GBOfficial regulatory label· revised October 10, 2025[1]

Allergic rhinitis, including hay fever and perennial rhinitis, vasomotor rhinitis. Allergic dermatoses, including pruritus, atopic eczema and contact dermatitis. Urticaria. Angioneurotic oedema, drug allergy.

How to take

Drug interactions

Known interactions involving Clemastine. Select one for details. This list is informational and not a complete interaction checker.

Potassium Chloride Potassium Citrate Propoxyphene Topiramate Zonisamide Acetylcholine Aclidinium Acrivastine Alfentanil Alprazolam Amantadine Amitriptyline Amobarbital Amoxapine Apomorphine Apraclonidine Aripiprazole Asenapine Atropine Azatadine Azelastine Baclofen Benzhydrocodone Biperiden Botulinum Toxin Type A Botulinum Toxin Type B Brexanolone Brexpiprazole Brimonidine Brivaracetam Bromocriptine Brompheniramine Buprenorphine Buspirone Butabarbital Butalbital Butorphanol Candida Albicans Cannabidiol Carbamazepine Carbamoylcholine Carbinoxamine Cariprazine Carisoprodol Cenobamate Cetirizine Chlorcyclizine Chlordiazepoxide Chlormezanone Chlorphenesin Chlorpheniramine Chlorpromazine Chlorzoxazone Citalopram Clidinium Clobazam Clomipramine Clonazepam Clonidine Clorazepate Clozapine Coccidioides Immitis Spherule Codeine Cyclizine Cyclobenzaprine Cyproheptadine Dantrolene Darifenacin Demecarium Desipramine Desvenlafaxine Deutetrabenazine Dexbrompheniramine Dexmedetomidine Dextromethorphan Dezocine Diazepam Dichloralphenazone Dicyclomine Dihydrocodeine Dimenhydrinate Diphenhydramine Disopyramide Donepezil Doxepin Doxylamine Dronabinol Droperidol Duloxetine Eluxadoline Entacapone Escitalopram Esketamine Eslicarbazepine Estazolam Eszopiclone Ethanol Ethchlorvynol Ethosuximide Ethotoin Ezogabine Felbamate Fentanyl Fesoterodine Flavoxate Flibanserin Fluoxetine Fluphenazine Flurazepam Fluvoxamine Fosphenytoin Gabapentin Galantamine Glycopyrronium Halazepam Haloperidol Histamine Hydrocodone Hydromorphone Hydroxyzine Hyoscyamine Ifosfamide Iloperidone Imipramine Ipratropium Isocarboxazid Isoflurophate Ketamine Lamotrigine Lasmiditan Lemborexant Levetiracetam Levocetirizine Levorphanol Linezolid Lithium Carbonate Lofexidine Loperamide Lorazepam Loxapine Lumateperone Lurasidone Maprotiline Meclizine Memantine Mepenzolate Meperidine Mephenytoin Mephobarbital Meprobamate Mesoridazine Metaxalone Methadone Methdilazine Methocarbamol Methotrimeprazine Methscopolamine Methsuximide Metoclopramide Metyrosine Midazolam Mirtazapine Molindone Morphine Nabilone Nalbuphine Nefazodone Nortriptyline Olanzapine Oliceridine Olopatadine Opicapone Opium Orphenadrine Oxazepam Oxcarbazepine Oxybutynin Oxycodone Oxymorphone Ozanimod Paliperidone Paraldehyde Paramethadione Paroxetine Pentazocine Pentobarbital Perampanel Pergolide Perphenazine Phenacemide Phenelzine Phenindamine Phenobarbital Phensuximide Phenyltoloxamine Phenytoin Physostigmine Pilocarpine Pimozide Pitolisant Pramipexole Pregabalin Primidone Procarbazine Prochlorperazine Procyclidine Promazine Promethazine Propantheline Propiomazine Protriptyline Pyrilamine Quazepam Quetiapine Ramelteon Rasagiline Remifentanil Remimazolam Revefenacin Risperidone Rivastigmine Ropinirole Rotigotine Rufinamide Scopolamine Secobarbital Sertraline Sibutramine Solifenacin Stiripentol Sufentanil Suvorexant Tacrine Tapentadol Tasimelteon Temazepam Tetrabenazine Thalidomide Thiethylperazine Thiopental

Showing 240 of 273. Type above to find a specific drug.

Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.

Sources & citations

[1]MHRA (UK) · PL002400561 · revised October 10, 2025

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.

Side effects & warnings

GBOfficial regulatory label· Adverse reactions· revised October 10, 2025[1]

Adverse reactions are listed below, by system organ class and frequency. Frequencies are defined as: very common (≥1/10); common (≥1/100, <1/10); uncommon (≥1/1,000, <1/100); rare (≥1/10,000, <1/1,000) very rare (<1/10,000). or not known (can not to beestimated from available data).
Adverse reactions identified during post-marketing use are reported voluntarily from a population of uncertain size, the frequency of these reactions is not known but likely to be rare or very rare MedDRA SOC Adverse Reaction Frequency Anaphylactic shock RareImmune system disorders Hypersensitivity reactions Rare Psychiatric disorders Excitability, especially in children Rare Sedation Common Dizziness Uncommon Headache Rare Nervous system disorders Fatigue Common Tachycardia Very rareCardiac disorder Palpitations Very rare Respiratory, thoracic and mediastinal disorders Dyspnoea Rare Abdominal pain Rare Nausea Rare Dry mouth Rare Gastrointestinal disorder Constipation Very rare Skin and Subcutaneous tissue disorders Skin rash Rare General system disorders Asthenia Rare Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

GBOfficial regulatory label· Warnings and precautions· revised October 10, 2025[1]

Antihistamines should be used with caution in patients with: • narrow-angle glaucoma • stenosing peptic ulcer • pyloroduodenal obstruction • prostatic hypertrophy with urinary retention and bladder neck obstruction. 8) • epilepsy or history of seizures • in the elderly, who are more likely to experience adverse effects such as paradoxical excitation.
Avoid use in elderly patients with confusion. • Do not exceed recommended dosage and duration of use without consulting a health care provider (See Dosage and Administration). Excipient Warning Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose -galactose malabsorption should not take this medicine.

This is not medical advice. Consult a qualified healthcare professional.

Overview

Regulatory status by market

GBUnited Kingdom· MHRA

Drug interactions

Drugs in the same class

Sources & citations